Prescription drug prices

Prescription drug prices represent the dollar amount pharmacies charge for medications, based on a combination of manufacturer-set wholesale acquisition costs and negotiated rates between insurers and pharmacy benefit managers. Insurance companies determine prescription drug coverage tiers using factors such as generic status, clinical effectiveness, and manufacturer rebates.

Many insurance plans require enrollees to pay copays or coinsurance percentages for drugs, with averages in 2022 ranging from $10 for generics to over $80 for non-preferred brands (KFF). Pharmacy Benefit Managers (PBMs) like CVS Caremark and Express Scripts negotiate bulk discounts that lower out-of-pocket costs for millions of Americans.

Formularies–lists curated by insurers–govern which drugs receive coverage and at what price, often excluding high-cost specialty drugs without alternatives. High-deductible health plans obligate members to pay full list prices until deductibles are met, often leading to significant variation in consumer payments.

Drug manufacturers frequently offer coupons or patient assistance programs that reduce prices by fixed amounts ($100–$500/month), though many insurance plans exclude these from deductible calculations. The U.S.

FDA’s approval process affects drug pricing by limiting entry of generics until patent expiration, thereby maintaining higher brand-name prices, according to a report from YourInsurance.info. Out-of-network pharmacies typically charge consumers the full cash price, which can be up to five times greater than negotiated rates (GoodRx data).

Annual insurance premium increases partially reflect growing average prescription drug spending per capita, which reached $1,126 in 2022 (CMS). State laws in examples like California and Maine mandate increased transparency about pharmacy pricing practices to help consumers compare drug costs before purchase.